CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Stroke and transient ischaemic attack
In the right clinical topic?
Age from 16 years onwards
This CKS topic is based on the National Institute for Health and Clinical Excellence (NICE) guideline Stroke: national clinical guideline for diagnosis and initial management of acute stroke and transient ischemic attack (TIA) [National Collaborating Centre for Chronic Conditions, 2008] and the third edition of the National clinical guideline for stroke developed by the Royal College of Physicians Intercollegiate Stroke Working Party [Intercollegiate Stroke Working Party, 2008]. This CKS topic takes account of the NICE Technology Appraisal Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events [NICE, 2005a] and the National stroke strategy [DH, 2007].
This CKS topic covers the primary care management of people presenting with:
- An acute stroke — ongoing neurological symptoms, or
- A transient ischaemic attack (TIA) — neurological symptoms resolved within 24 hours, or
- Complications and consequences of stroke — after rehabilitation has commenced.
This CKS topic does not cover the management in hospital or specialist centres of people with strokes or TIAs, or the prevention of stroke and TIA in people who are in atrial fibrillation.
There are separate CKS topics on Antiplatelet treatment, Atrial fibrillation, CVD risk assessment and management, Diabetes type 2, Hypertension - not diabetic, and Lipid modification - CVD prevention.
The target audience for this CKS topic is healthcare professionals working within the NHS in England, and providing first contact or primary health care. Patient information from NHS Choices is intended to be printed and given to people with this condition or their carers.
© NHS Institute for Innovation and Improvement